• Daily Marijuana Observer Facebook
  • Daily Marijuana Observer Twitter
  • Daily Marijuana Observer StockTwits
  • Daily Marijuana Observer SA
  • Daily Marijuana Observer Instagram
  • Daily Marijuana Observer Youtube
  • Pinterest Social Icon
  • Daily Marijuana Observer Talk Market

Anandia Labs Successfully Exports Cannabis Products to Australia

January 8, 2018


Vancouver, Canada -- January 8, 2018 -- / D.M.O. Newswire / -- Anandia Laboratories Inc. (“Anandia Labs” or the “Company”), a leading Canadian cannabis biotechnology and testing company, announced that it has successfully completed its first export (the “Export”) of Canadian cannabis oil for use in Australia. The Export was conducted on behalf of one of the Company’s clients, a Canadian-based licensed cannabis producer, to facilitate a clinical trial program. Anandia Labs is one of only 33 entities with a Health Canada Dealers Licence (“Dealers Licence”) that permits activities with cannabis, enabling the Company to export cannabis products internationally and import cannabis products into Canada.


“Demand for Canadian medical cannabis is growing internationally, given the stringent quality control measures stipulated by Canadian regulations and the resulting quality of the product,” said Dr. Jonathan Page, President and CEO of Anandia Labs. “Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”) are rapidly becoming the international gold standard for medical cannabis production. This positions Licensed Dealers such as Anandia Labs as the go-to global players in providing certified cannabis products and disease-free genetic propagative material to licenced cannabis producers in Canada and worldwide. By providing Canadian-leading testing, genetics and extraction services, as well as acting as a conduit for the import and export of certified cannabis products, we are actively assisting our clients to develop their product pipelines and grow their businesses in a rapidly growing global industry.”


Anandia Labs’ Dealers Licence enables the Company to import/export, buy/sell, store, dispose of and trade all forms of cannabis, including dried flower and oils. The ACMPR requires mandatory quality control and product testing of all cannabis products destined for sale, with testing currently being conducted by Licensed Dealers. Anandia Labs is Canada’s leading independent cannabis analytics and genetics testing company, with approximately a 20% market share under the ACMPR. The Company operates out of a 5,400 square foot facility in Vancouver, British Columbia and has plans to construct a 40,000 square foot purpose-built cannabis innovation centre in British Columbia during 2018.


Anandia Labs is 19% owned by CannaRoyalty Corp., an active investor and operator in the legal cannabis industry and a Canadian publicly-traded company (CSE:CRZ) (OTCQX: CNNRF).


About Anandia Labs


Anandia Labs is a biotechnology company focused exclusively on cannabis, with the aim of bringing the best of modern science to the cannabis industry for the benefit of growers and consumers. Anandia Labs provides industry leading analytical testing services including potency, pesticides, microbes and terpenes to Licenced Producers and patients. In addition, Anandia Labs uses its cannabis-specific scientific expertise to assist its customers in the analysis of their testing results and resolution of any detected non-conformities.


Anandia Labs has also completed extensive research into cannabis genetics and has built a significant collection of cannabis germplasm. The Company uses modern plant breeding approaches to develop next generation cannabis varieties. Anandia Labs holds a Dealers Licence from Health Canada pursuant to the provisions of the Controlled Drugs and Substances Act and the Narcotic Control Regulations. The Dealers Licence permits Anandia Labs to analyze and extract cannabis, as well as cultivate cannabis for breeding and strain improvement.


For further information, please contact:

Jonathan Page, President and CEO

ir@anandialabs.com; 604-822-0253


Media inquiries:

Lana Culley, Director of Business Development

lculley@anandialabs.com; 289-968-4585


Cautionary Statement on Forward-Looking Information


Certain information contained in this press release, including any information as to Anandia Laboratories Inc.’s (the “Corporation”) strategy, projects, plans or future financial or operating performance, constitutes "forward-looking statements". All statements, other than statements of historical fact, are forward-looking statements. The words "will", "expect", "continue", "assess", "positions" and similar expressions identify forward-looking statements. Forward-looking statements are necessarily based upon a number of estimates and assumptions; including material estimates and assumptions that, while considered reasonable by the Corporation as at the date of this press release in light of each of management's experience and perception of current conditions and expected developments, are inherently subject to significant business, economic and competitive uncertainties and contingencies. Known and unknown factors could cause actual results to differ materially from those projected in the forward-looking statements and undue reliance should not be placed on such statements and information. Any forward-looking statements included in this document are made as of the date of this document and the Corporation disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Although management of the Corporation believes that the expectations represented in such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct.

Please reload

Please reload

Please reload


© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.